
Royalty Pharma plc
RPRXHealthcare|Medical - Pharmaceuticals|US
$67.30
-0.27 (-0.40%)
DCF Value
$20.18
Tangible Book / Share
$19.93
Graham Number
$22.85
Cash / Share
$1.22
Ownership Breakdown
94.0%
Float
445.3M
Shares Outstanding
418.4M
Float Shares
Major Holders (22)
Combined: 117.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Legorreta G. Pablo | Individual | 18.73% | 101,785,843 | Aug 17, 2026 | 13D/G |
| Morgan Stanley | HC, CO | 9.20% | 38,907,011 | Aug 5, 2025 | 13D/G |
| Capital International Investors | Investment adviser | 8.80% | 37,772,419 | May 14, 2026 | 13D/G |
| Morgan Stanley Investment Management Inc. | IA, CO | 8.50% | 35,864,664 | Aug 5, 2025 | 13D/G |
| Legorreta Investments, LLC | Other | 7.76% | 37,535,019 | Aug 17, 2026 | 13D/G |
| R & H Trust Co. (Guernsey) Limited | Corporation | 5.70% | 24,223,082 | Feb 20, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.70% | 25,445,414 | Feb 4, 2025 | 13D/G |
| Butterfield Fiduciary Administrators Trust Company Limited | Corporation | 4.80% | 21,366,927 | Jun 16, 2026 | 13D/G |
| Severgnini Achille G. | Individual | 4.80% | 21,366,927 | Jun 16, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 4.30% | 19,288,880 | Nov 5, 2026 | 13D/G |
| FMR LLC | Holding company | 4.30% | 19,288,880 | Nov 5, 2026 | 13D/G |
| General Atlantic, L.P. | Partnership | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| General Atlantic (RP) Collections, LLC | Other | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| General Atlantic GenPar, L.P. | Partnership | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| General Atlantic (SPV) GP, LLC | Other | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| GAP Coinvestments V, LLC | Other | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| GAP Coinvestments IV, LLC | Other | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| GAP Coinvestments III, LLC | Other | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| GAP Coinvestments CDA, L.P. | Partnership | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| General Atlantic Partners AIV-1 B, L.P. | Partnership | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| General Atlantic Partners AIV-1 A, L.P. | Partnership | 3.20% | 14,243,870 | Aug 14, 2025 | 13D/G |
| The Vanguard Group | Investment adviser | 2.52% | 10,936,538 | Oct 30, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,037,366 acquired · 1,377,223 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Coyne Terrance P. | EVP & CFO | Nov 6, 2026 | CONVERSION | 10,000 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Nov 6, 2026 | CONVERSION | 150,000 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Nov 6, 2026 | CONVERSION | 15,000 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Nov 6, 2026 | CONVERSION | 100,000 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Nov 4, 2026 | AWARD | 7,122 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Nov 6, 2026 | CONVERSION | 15,000 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Nov 6, 2026 | CONVERSION | 150,000 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Nov 4, 2026 | AWARD | 5,341 | — | — | Form 4 |
| Legorreta Pablo G. | director, officer: CEO, Chairman of the Board | Nov 4, 2026 | AWARD | 42,209 | — | — | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Nov 4, 2026 | AWARD | 7,122 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Oct 5, 2026 | SELL | 4,126 | $57.10 | $235.6K | Form 4 |
| Bassler Bonnie L | director | Sep 30, 2026 | AWARD | 642 | $58.41 | $37.5K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Sep 28, 2026 | SELL | 4,126 | $57.88 | $238.8K | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Sep 22, 2026 | SELL | 96,073 | $58.51 | $5.6M | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Sep 22, 2026 | SELL | 3,927 | $58.93 | $231.4K | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Aug 18, 2026 | SELL | 100,000 | $59.97 | $6.0M | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Aug 19, 2026 | GIFT | 16,800 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Aug 13, 2026 | SELL | 9,230 | $58.59 | $540.8K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Aug 13, 2026 | SELL | 1,772 | $59.14 | $104.8K | Form 4 |
| Legorreta Pablo G. | director, officer: CEO, Chairman of the Board | Aug 5, 2026 | AWARD | 65,216 | — | — | Form 4 |
| Legorreta Pablo G. | director, officer: CEO, Chairman of the Board | Aug 7, 2026 | GIFT | 30,000 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Aug 7, 2026 | GIFT | 18,500 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Aug 5, 2026 | AWARD | 11,002 | — | — | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Aug 5, 2026 | AWARD | 11,002 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Aug 7, 2026 | GIFT | 3,000 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Aug 5, 2026 | AWARD | 8,252 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jul 1, 2026 | SELL | 9,099 | $55.88 | $508.5K | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Jun 30, 2026 | SELL | 97,446 | $56.50 | $5.5M | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Jun 30, 2026 | SELL | 2,554 | $57.10 | $145.8K | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Jun 30, 2026 | SELL | 29,400 | $56.44 | $1.7M | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Jun 30, 2026 | SELL | 600 | $57.09 | $34.3K | Form 4 |
| Bassler Bonnie L | director | Jun 30, 2026 | AWARD | 689 | $54.40 | $37.5K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jun 24, 2026 | SELL | 9,098 | $55.18 | $502.1K | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Jun 23, 2026 | SELL | 32,408 | $54.11 | $1.8M | Form 4 |
| Hite Christopher | EVP & Chairman, Partnering | Jun 23, 2026 | SELL | 117,592 | $54.47 | $6.4M | Form 4 |
| WEATHERMAN ELIZABETH H | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| Norden Gregory | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| LOVE TED W | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| HODGSON DAVID C | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| Ho Carole | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| Engelbert Catherine M. | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| Coric Vlad | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| Bassler Bonnie L | director | Jun 5, 2026 | AWARD | 4,545 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | May 26, 2026 | SELL | 64,399 | $53.98 | $3.5M | Form 4 |
| Urist Marshall | EVP, Research & Investments | May 20, 2026 | SELL | 13,684 | $52.75 | $721.8K | Form 4 |
| Urist Marshall | EVP, Research & Investments | May 14, 2026 | SELL | 13,684 | $53.06 | $726.1K | Form 4 |
| Norden Gregory | director | May 14, 2026 | SELL | 3,045 | $53.00 | $161.4K | Form 4 |
| Legorreta Pablo G. | director, officer: CEO, Chairman of the Board | May 6, 2026 | AWARD | 143,821 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | May 6, 2026 | AWARD | 24,263 | — | — | Form 4 |
| Hite Christopher | EVP & Vice Chairman | May 6, 2026 | AWARD | 24,263 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | May 6, 2026 | AWARD | 18,197 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Apr 28, 2026 | SELL | 1,875 | $49.78 | $93.3K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Apr 28, 2026 | SELL | 32,916 | $49.78 | $1.6M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Apr 1, 2026 | SELL | 1,875 | $48.33 | $90.6K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Apr 1, 2026 | SELL | 32,916 | $48.33 | $1.6M | Form 4 |
| Bassler Bonnie L | director | Mar 31, 2026 | AWARD | 815 | $45.98 | $37.5K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Mar 23, 2026 | SELL | 32,916 | $45.53 | $1.5M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Mar 23, 2026 | SELL | 1,875 | $45.53 | $85.4K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Mar 2, 2026 | SELL | 22,487 | $46.67 | $1.0M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Mar 2, 2026 | SELL | 10,429 | $47.01 | $490.3K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Mar 2, 2026 | SELL | 1,292 | $46.67 | $60.3K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Mar 2, 2026 | SELL | 583 | $47.01 | $27.4K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 23, 2026 | SELL | 32,916 | $45.32 | $1.5M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 23, 2026 | SELL | 1,875 | $45.32 | $85.0K | Form 4 |
| Legorreta Pablo G. | director, officer: CEO, Chairman of the Board | Feb 11, 2026 | AWARD | 157,828 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 11, 2026 | AWARD | 26,626 | — | — | Form 4 |
| Hite Christopher | EVP & Vice Chairman | Feb 11, 2026 | AWARD | 26,626 | — | — | Form 4 |
| Urist Marshall | EVP, Research & Investments | Feb 11, 2026 | AWARD | 19,970 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 2, 2026 | SELL | 102,581 | $42.08 | $4.3M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 3, 2026 | SELL | 108,759 | $42.84 | $4.7M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 4, 2026 | SELL | 19,076 | $43.29 | $825.9K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 2, 2026 | SELL | 5,843 | $42.08 | $245.9K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 3, 2026 | SELL | 6,195 | $42.84 | $265.4K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Feb 4, 2026 | SELL | 1,087 | $43.29 | $47.1K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jan 30, 2026 | SELL | 20,000 | $41.09 | $821.8K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jan 23, 2026 | SELL | 20,000 | $40.26 | $805.1K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Jan 20, 2026 | SELL | 65,832 | $39.35 | $2.6M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Jan 20, 2026 | SELL | 3,750 | $39.35 | $147.6K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jan 16, 2026 | SELL | 20,000 | $39.52 | $790.3K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jan 9, 2026 | SELL | 20,000 | $40.78 | $815.6K | Form 4 |
| McGivern Arthur Richard | EVP, Investments & GC | Jan 1, 2026 | OTHER | 24,441 | — | — | Form 4 |
| McGivern Arthur Richard | EVP, Investments & GC | Jan 1, 2026 | OTHER | 706,393 | — | — | Form 4 |
| Coyne Terrance P. | EVP & CFO | Jan 2, 2026 | SELL | 65,832 | $38.42 | $2.5M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Jan 2, 2026 | SELL | 3,750 | $38.42 | $144.1K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Jan 2, 2026 | SELL | 20,000 | $38.48 | $769.6K | Form 4 |
| Bassler Bonnie L | director | Dec 31, 2025 | AWARD | 967 | $38.74 | $37.5K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 26, 2025 | SELL | 20,000 | $39.32 | $786.4K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 19, 2025 | SELL | 20,000 | $38.38 | $767.6K | Form 4 |
| Lloyd George W. | EVP, Investments & CLO | Dec 17, 2025 | SELL | 79,346 | $38.57 | $3.1M | Form 4 |
| Lloyd George W. | EVP, Investments & CLO | Dec 18, 2025 | SELL | 30,654 | $38.50 | $1.2M | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 16, 2025 | SELL | 20,000 | $38.32 | $766.4K | Form 4 |
| Coyne Terrance P. | EVP & CFO | Dec 15, 2025 | SELL | 65,832 | $38.36 | $2.5M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Dec 15, 2025 | SELL | 3,750 | $38.36 | $143.9K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 5, 2025 | SELL | 23,334 | $39.15 | $913.6K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 5, 2025 | SELL | 18,242 | $39.15 | $714.2K | Form 4 |
| Lloyd George W. | EVP, Investments & CLO | Dec 3, 2025 | SELL | 110,000 | $39.77 | $4.4M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Dec 1, 2025 | SELL | 65,832 | $39.87 | $2.6M | Form 4 |
| Coyne Terrance P. | EVP & CFO | Dec 1, 2025 | SELL | 3,750 | $39.87 | $149.5K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 1, 2025 | SELL | 23,333 | $39.93 | $931.6K | Form 4 |
| Urist Marshall | EVP, Research & Investments | Dec 1, 2025 | SELL | 18,242 | $39.90 | $727.9K | Form 4 |